Published in Lancet on May 11, 1991
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med (1992) 2.48
A femtomolar-acting neuroprotective peptide. J Clin Invest (1996) 1.85
Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther (2007) 1.80
Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol (2009) 1.75
Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol (1996) 1.67
Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol (1995) 1.63
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol (1994) 1.56
Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol (1996) 1.55
MiR-21 in Extracellular Vesicles Leads to Neurotoxicity via TLR7 Signaling in SIV Neurological Disease. PLoS Pathog (2015) 1.50
HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest (1998) 1.49
Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiatry (1998) 1.43
Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology (2010) 1.36
Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol (2001) 1.35
Disrupted brain networks in the aging HIV+ population. Brain Connect (2012) 1.25
Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1997) 1.17
Structural brain alterations can be detected early in HIV infection. Neurology (2012) 1.15
Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol (1994) 1.14
HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Front Biosci (2008) 1.11
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol (2013) 1.08
Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. Am J Pathol (2002) 1.07
Platelet-derived growth factor protects neurons against gp120-mediated toxicity. J Neurovirol (2008) 1.07
Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am J Pathol (2006) 1.06
Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J Neurol Neurosurg Psychiatry (1993) 1.05
Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One (2013) 1.05
Infectious agents and neurodegeneration. Mol Neurobiol (2012) 1.03
Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry (1998) 0.99
Neuroprotective activities of CEP-1347 in models of neuroAIDS. J Immunol (2009) 0.98
Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother (2004) 0.97
Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study. J Neurol Neurosurg Psychiatry (1998) 0.96
Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study. Acta Neuropathol (1993) 0.96
Up-regulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1. FASEB J (2013) 0.96
Brain atrophy in HIV infection is more strongly associated with CDC clinical stage than with cognitive impairment. J Int Neuropsychol Soc (1997) 0.95
Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev (1993) 0.94
Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS. J Neurovirol (2008) 0.91
Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J Virol (2003) 0.91
Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression. J Virol (1998) 0.90
Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. Am J Pathol (1996) 0.90
Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder. Int J Tryptophan Res (2010) 0.90
Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis. Exp Neurol (2007) 0.89
Cerebral atrophy in AIDS: a stereological study. Acta Neuropathol (1993) 0.87
Viral diseases of the central nervous system. Curr Opin Virol (2015) 0.87
Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta. PLoS One (2012) 0.86
Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis. Future Virol (2010) 0.86
Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.85
Neuronal toxicity in HIV CNS disease. Future Virol (2012) 0.85
ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling. Synapse (2010) 0.85
Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders. J Neuroimmune Pharmacol (2014) 0.84
Antioxidant protection from HIV-1 gp120-induced neuroglial toxicity. J Neuroinflammation (2004) 0.83
Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy. Neuroreport (2003) 0.83
Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc Natl Acad Sci U S A (1996) 0.83
Deep gray matter structures in HIV infection: a proton MR spectroscopic study. AJNR Am J Neuroradiol (1996) 0.82
From human immunodeficiency virus (HIV) infection of the brain to dementia. Genitourin Med (1997) 0.82
HIV leucoencephalopathy and TNFalpha expression in neurones. J Neurol Neurosurg Psychiatry (2005) 0.82
Serial MRI of the brain in asymptomatic patients infected with HIV: results from the UCMSM/Medical Research Council neurology cohort. J Neurol Neurosurg Psychiatry (1994) 0.81
HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death. Br J Pharmacol (2001) 0.80
Post mortem examinations of HIV infected patients: a nationwide survey. J Clin Pathol (1993) 0.80
The Differences between Blast-Induced and Sports-Related Brain Injuries. Front Neurol (2013) 0.79
Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons. J Neurovirol (2009) 0.79
In vivo modeling of HIV-1 mediated neurodegeneration. Am J Pathol (1996) 0.78
Analysis of metabolic changes of brain in HIV-1 seropositive patients with proton magnetic resonance spectroscopy. Pol J Radiol (2010) 0.78
Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy. J Neuroinflammation (2016) 0.76
Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND. Brain Sci (2017) 0.75
Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems. Curr HIV Res (2016) 0.75
Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats. PLoS One (2017) 0.75
Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells. Oncotarget (2017) 0.75
The pathogenesis of the neurological complications of HIV-1 infection. Genitourin Med (1993) 0.75
Effect of infection with the 139H scrapie strain on the number, area and/or location of hypothalamic CRF- and VP-immunostained neurons. Acta Neuropathol (1994) 0.75
Neuronal loss in frontal cortex in HIV infection. Lancet (1991) 0.75
Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIV. J Neurovirol (2015) 0.75
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci (1989) 4.01
Prion dementia without characteristic pathology. Lancet (1990) 3.66
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett (1998) 3.26
Corticobasal degeneration. Brain (1989) 3.20
Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature (1996) 3.09
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A (2000) 2.50
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol (1999) 1.89
Diagnosing dementia: do we get it right? BMJ (1988) 1.85
Brain capillary endothelial cells in vitro lack surface IgG Fc receptors. Neurosci Lett (1986) 1.74
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry (1994) 1.60
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
Diagnostic criteria for corticobasal degeneration. J Neurol Neurosurg Psychiatry (2000) 1.48
Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain (2000) 1.43
The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain (1994) 1.41
Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. J Neurol Neurosurg Psychiatry (1989) 1.41
The fine structure of periventricular pleomorphic gliomas induced transplacentally by N-ethyl-N-nitrosourea in BD-IX rats. With a note on their origin. J Neurol Sci (1972) 1.38
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
Brain tissue banks in psychiatric and neurological research. J Clin Pathol (1996) 1.38
Characterization of the human cell line TE671. Carcinogenesis (1989) 1.34
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol (1996) 1.32
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci (1992) 1.21
Studies of the morphology and tumorigenicity of experimental brain tumours in tissue culture. Br J Exp Pathol (1976) 1.20
Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport (2001) 1.19
Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumour necrosis factor and interleukin-1. Immunology (1988) 1.17
The origin of experimental brain tumours: a sequential study. Experientia (1976) 1.17
The development of experimental brain tumours. A sequential light and electron microscope study of the subependymal plate. I. Early lesions (abnormal cell clusters). Acta Neuropathol (1979) 1.14
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14
Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci (1999) 1.14
Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol (1994) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similar? Lancet (1997) 1.14
Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology (2000) 1.13
Prion protein immunocytochemistry--UK five centre consensus report. Neuropathol Appl Neurobiol (1997) 1.13
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol (1996) 1.12
Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Brain Res Rev (2001) 1.11
Distribution and fine structural analysis of undifferentiated cells in the primate subependymal layer. J Anat (1991) 1.10
Pick's disease is associated with mutations in the tau gene. Ann Neurol (2000) 1.10
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis. J Neurol Sci (1981) 1.09
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol (1999) 1.07
Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J Neurol Neurosurg Psychiatry (1993) 1.05
Chemical carcinogenesis in the nervous system. Int Rev Exp Pathol (1976) 1.05
Quantitative analysis of tau isoform transcripts in sporadic tauopathies. Brain Res Mol Brain Res (2005) 1.04
beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol (1999) 1.04
HIV-associated brain pathology in the United Kingdom: an epidemiological study. AIDS (1997) 1.03
Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry (1993) 1.01
A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann Neurol (2000) 1.00
TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (2000) 0.99
Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett (1992) 0.99
Immunocytochemistry of cerebellar astrocytomas: with a special note on Rosenthal fibres. Acta Neuropathol (1985) 0.98
Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol (2000) 0.98
The role of glutamine synthetase in the diagnosis of cerebral tumours. Neuropathol Appl Neurobiol (1982) 0.96
Correlation of MRI and neuropathology in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.96
The vasculature of experimental brain tumours. Part 2. A quantitative assessment of morphological abnormalities. J Neurol Sci (1981) 0.94
Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease. Psychiatry Clin Neurosci (2000) 0.94
Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochem J (1991) 0.94
Macrophages in brain tumours induced transplacentally by N-ethyl-N-nitrosourea in rats: an electron-microscope study. J Pathol (1975) 0.94
Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system. Neuroscience (1989) 0.94
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2008) 0.93
A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology (1996) 0.93
An electron microscope study of reacting astrocytes in gliomas induced by n-ethyl-n-nitrosourea in rats. Acta Neuropathol (1974) 0.93
A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration. Exp Neurol (2000) 0.93
Cell lines (VMDk) derived from a spontaneous murine astrocytoma. Morphological and immunocytochemical characterization. J Neurol Sci (1983) 0.93
Cerebral damage in paraquat poisoning. Histopathology (1980) 0.92
Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett (1997) 0.92
Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathol (1998) 0.91
Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature (1988) 0.91
Ultrastructural examination is essential for diagnosis of papillary meningioma. Histopathology (2001) 0.91
The fine structure of blood vessels in ethylnitrosourea-induced tumours of the rat nervous system: with special reference to the breakdown of the blood-brain barrier. Br J Exp Pathol (1976) 0.91
Cell proliferation in the subependymal layer of the postnatal marmoset, Callithrix jacchus. Brain Res Dev Brain Res (1990) 0.91
Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques. Neuropathol Appl Neurobiol (2001) 0.91
A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt-Jakob disease (vCJD). Neuropathol Appl Neurobiol (2009) 0.90
What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? Neuropathology (2001) 0.90
Norrie disease and peripheral venous insufficiency. Br J Ophthalmol (2004) 0.89
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Res (2002) 0.89
Spatial correlations between the vacuolation, prion protein deposits, and surviving neurons in the cerebral cortex in sporadic Creutzfeldt-Jakob disease. Neuropathology (2001) 0.89
Beta A4 deposition in the temporal cortex of adults with Down's syndrome. J Neurol Sci (1992) 0.88
Vitreous amyloidosis in alanine 71 transthyretin mutation. Br J Ophthalmol (2005) 0.88
Two unusual osteogenic orbital tumors: presumed parosteal osteosarcomas of the orbit. Ophthalmology (2001) 0.88
Fine structural localisation of acid phosphatase in neural tumours induced by N-ethyl-N-nitrosourea in rats. Acta Neuropathol (1974) 0.88